A Summary of Online Enquiries Submitted to Anti-doping Hotline 2005–2018

Anabolic Androgenic Steroid (AAS) abuse in the society is considered a health problem and has been associated with cardiovascular toxicity, endocrine disruption, as well as psychiatric symptoms such as aggression and cognitive dysfunction. Men and women abusing AAS, as well as persons in close relationship to AAS abusers, may encounter concerns. Subsequently, the Anti-Doping Hotline was formed 1993 to answers questions about doping in the society. Here we have reviewed 7,123 enquiries posted on the Anti-Doping Hotline website between 2005 and 2018 to see what type of questions were raised. Most questions (n = 2,924) involved AAS, 60% from abusers themselves, and 17% from a person close to an AAS abusers. Only 2.3% of the questions concerned AAS abusing women. Of the AAS specific questions most were from persons who sought personal advice regarding risks and side effects. Notably, the AAS abusers themselves were concerned about somatic side effects (e.g., gynecomastia) and problems related to the AAS injection. The persons in close relationship to an AAS abusers on the other hand, expressed concerns about psychiatric changes including mood swings and aggressivity. In addition to AAS, 26 and 13% of the questions involved dietary supplements and other doping substances, respectively. A gradual decrease of questions regarding ephedrine was noted, whereas the numbers of SARMs related questions increased during this time. Our results show that there is a continuous need to provide medical, nursing, and social support and counseling to AAS abusers and their next of kin.

[1]  O. Beck,et al.  [Increased availability needed for analysis of anabolic androgenic steroids outside of sports - proposal of a uniform clinical analysis method in Sweden]. , 2021, Lakartidningen.

[2]  C. Castagna,et al.  UEFA expert group statement on nutrition in elite football. Current evidence to inform practical recommendations and guide future research , 2020, British Journal of Sports Medicine.

[3]  L. Mondello,et al.  Reliable identification and quantification of anabolic androgenic steroids in dietary supplements by using gas chromatography coupled to triple quadrupole mass spectrometry. , 2020, Drug testing and analysis.

[4]  E. Dworatzek,et al.  Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials , 2020, Expert opinion on investigational drugs.

[5]  L. Ekström,et al.  Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality , 2020, Medicina.

[6]  L. Ekström,et al.  Studies of Athlete Biological Passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents. , 2020, Drug testing and analysis.

[7]  M. L. Jørstad,et al.  Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires , 2019, Substance Abuse Treatment, Prevention, and Policy.

[8]  M. Kaufman,et al.  Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia? , 2019, Neuroscience & Biobehavioral Reviews.

[9]  E. Medin,et al.  Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden – a longitudinal population-based register study , 2018, Neuropsychiatric disease and treatment.

[10]  R. Maughan,et al.  Athletes and Supplements: Prevalence and Perspectives. , 2018, International journal of sport nutrition and exercise metabolism.

[11]  E. Medin,et al.  Prevalence, Patient Characteristics, and Pharmacological Treatment of Children, Adolescents, and Adults Diagnosed With ADHD in Sweden , 2018, Journal of attention disorders.

[12]  B. Anawalt Detection of anabolic androgenic steroid use by elite athletes and by members of the general public , 2017, Molecular and Cellular Endocrinology.

[13]  M. Thevis,et al.  Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border , 2017, Substance use & misuse.

[14]  M. Thevis,et al.  Detection of SARMs in doping control analysis , 2017, Molecular and Cellular Endocrinology.

[15]  L. Ekström,et al.  Recruitment to doping and help-seeking behavior of eight female AAS users , 2016, Substance Abuse Treatment, Prevention, and Policy.

[16]  J. Dalton,et al.  Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer , 2013, Current opinion in supportive and palliative care.

[17]  S. Lakhan,et al.  Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects , 2012, Brain and behavior.

[18]  J. Ahlner,et al.  Anabolic androgenic steroids in police cases in Sweden 1999-2009. , 2012, Forensic science international.

[19]  J. Bojsen-Møller,et al.  Use of performance‐ and image‐enhancing substances among recreational athletes: a quantitative analysis of inquiries submitted to the Danish anti‐doping authorities , 2010, Scandinavian journal of medicine & science in sports.

[20]  R. Wood,et al.  Anabolic-androgenic steroid dependence: an emerging disorder. , 2009, Addiction.

[21]  J. Darkes,et al.  Journal of the International Society of Sports Nutrition Open Access a League of Their Own: Demographics, Motivations and Patterns of Use of 1,955 Male Adult Non-medical Anabolic Steroid Users in the United States , 2007 .

[22]  N. Evans,et al.  Anabolic androgenic steroids: a survey of 500 users. , 2006, Medicine and science in sports and exercise.

[23]  H. Geyer,et al.  Analysis of Non-Hormonal Nutritional Supplements for Anabolic-Androgenic Steroids - Results of an International Study , 2004, International journal of sports medicine.

[24]  A. Rane,et al.  The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology , 2003, European Journal of Clinical Pharmacology.

[25]  L. Woodhouse,et al.  Proof of the effect of testosterone on skeletal muscle. , 2001, The Journal of endocrinology.

[26]  P. de Backer,et al.  Detection and determination of anabolic steroids in nutritional supplements. , 2001, Journal of Pharmaceutical and Biomedical Analysis.

[27]  N. Evans,et al.  Gym and tonic: a profile of 100 male steroid users. , 1997, British journal of sports medicine.